The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rovalpituzumab tesirine (Rova-T) as a therapeutic agent for Neuroendocrine Prostate Cancer (NEPC).
 
Loredana Puca
No Relationships to Disclose
 
Verena Sailer
No Relationships to Disclose
 
Kaitlyn Gayvert
No Relationships to Disclose
 
Kumiko Isse
Employment - Abbvie/Stemcentrx
 
Michael Sigouros
No Relationships to Disclose
 
David M. Nanus
Consulting or Advisory Role - Roche/Genentech
 
Scott T. Tagawa
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Endocyte; Genentech; Immunomedics; Janssen; Medivation; Sanofi
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech (Inst); Immunomedics (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Newlink Genetics (Inst); Novartis (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Stem CentRx (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Juan Miguel Mosquera
No Relationships to Disclose
 
Laura Saunders
Employment - Abbvie/Stemcentrx
 
Himisha Beltran
Consulting or Advisory Role - Bayer; Genzyme; Janssen Oncology
Research Funding - Abbvie/Stemcentrx; Astellas Pharma (Inst); Janssen (Inst); Lilly (Inst); Millennium (Inst)